Steven Patierno PhD

Steven Patierno

Core Faculty

Steven Patierno, PhD

Degree

PhD, University of Texas Medical School at Houston

Dr. Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research.   He is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.

Al Abo M, Foo W-C, Howard LE, McGue S, Lacroix B, Kephart J, et al. Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence. NPJ Precis Oncol. 2025 Jan 29;9(1):30.

Mukherjee D, Previs RA, Haines C, Al Abo M, Juras PK, Strickland KC, et al. Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis. 2024.